Evolution of Healthcare
Moving into the new era of ‘Wellcare’
It has long been our vision to make disease a thing of the past, but in order to get there, we know healthcare across our region needs to adapt and evolve into a sustainable and resilient ecosystem, prepared for the next generation of therapies.
J&J Innovative Medicine’s Focus: Digital Healthcare Innovation
Recent global events, including the COVID-19 pandemic, have put healthcare in the spotlight, revealing many areas where collaboration is essential if we are to progress. Our focus is always on ensuring patients get the best possible outcomes. And we believe the current wave of digital healthcare solutions can help achieve the ‘triple aim’ of improving an individual’s experience of care, improving the health of populations and reducing the per capita costs of care.
Among many others, two areas of digital innovation where we are partnering with others to make a meaningful difference for tomorrow are in Real-World Evidence and Health Technology Assessment of Innovation in Cancer.
Among many others, two areas of digital innovation where we are partnering with others to make a meaningful difference for tomorrow are in Real-World Evidence and Health Technology Assessment of Innovation in Cancer.
Through cell and gene therapies, the next generation of cancer breakthroughs are on the horizon, but how can we evaluate them fairly and swiftly, to ensure patients have access to these treatments?
By harnessing vast amounts of health data, we can help unlock a new body of evidence, which can increase disease understanding, help everyone in healthcare to make better decisions, and ultimately improve clinical practice and health outcomes for patients.
With the next generation of therapies within our reach, we want to do all we can to ensure healthcare systems across our region are prepared for this shift. We cannot do this alone and welcome healthy discussion with all our stakeholders, so together we can move closer to a world where disease is a thing of the past.”
Martin Price
Vice President of Health Economics, Market Access and Reimbursement, J&J Innovative Medicine EMEA
Discover our careers or
collaborate with us
You are now leaving J&J Innovative Medicine EMEA
We inform you that the privacy policy at the remote site can be different from J&J Innovative Medicine EMEA. Click continue to proceed.